Cyclopent 1% Eye Drop
Cyclopent 1% Eye Drop

Cyclopent 1% Eye Drop

 

Cyclopent 1% Eye Drop Trade Information

  • Minimum Order Quantity
  • 100000 Pieces
  • Payment Terms
  • Cash in Advance (CID), Cash Advance (CA)
  • Supply Ability
  • 100000 Pieces Per Week
  • Delivery Time
  • 1 Week
  • Main Export Market(s)
  • Australia, Western Europe, Middle East, Central America, Africa, South America, Asia, Eastern Europe, North America
 

About Cyclopent 1% Eye Drop

CYCLOPENT 1%

Cyclopent - Cyclopent Hydrochloride Ophthalmic Solution USP, 1% is an anticholinergic prepared as a sterile, borate buffered, solution for topical ocular use. Cyclopent (Cyclopent OPHTHALMIC) is indicated for the following: Cyclopent Hydrochloride Ophthalmic Solution is used to produce mydriasis and cycloplegia in diagnostic procedures. Active ingredients: Cyclopentolate

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Pharmaceutical Drugs Category

Nystatin Syrup

Nystatin Syrup

Price 75 INR / Bottle

Minimum Order Quantity : 10000 Bottles

Physical Form : Liquid

Drug Type : Specific Drug

Recommended For : Blood

Dosage : 200 mg

Pediasure Dietary Supplements

Pediasure Dietary Supplements

Price 880 INR

Minimum Order Quantity : 100000 Pieces

Physical Form : Powder

Drug Type : Health Supplements

Recommended For : Kids Grow

STUKINASE 1500000 IU Streptokinase Injection

STUKINASE 1500000 IU Streptokinase Injection

Price 1800 INR

Minimum Order Quantity : 100000 Pieces

Physical Form : Liquid

Drug Type : Injection

Recommended For : Heart Attack

Hepcvir Tablet (Cipla)

Hepcvir Tablet (Cipla)

Price 15000 INR

Minimum Order Quantity : 10000000 Pieces

Physical Form : Tablets

Drug Type : Specific Drug

Dosage : 400 mg



"Accepting orders in bulk order quantity".
trade india member
DHEER HEALTHCARE PRIVATE LIMITED All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.